Deal facts
- Buyer
- Johnson & Johnson
- Target
- Intra-Cellular Therapies, Inc.
- Deal value
- USD 14,600,000,000
- Announced
- 2 April 2025
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash
Sources
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CompletedClosed
Johnson & Johnson completes acquisition of Intra-Cellular Therapies, Inc.
Item 2.01 Completion of Acquisition or Disposition of Assets. The information set forth in the Introduction, Item 3.01, Item 3.03, Item 5.01, Item 5.02 and Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information set forth in the Intr
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Merck to acquire Terns Pharmaceuticals, Inc.
Merck and Terns Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Merck
- Target
- Terns Pharmaceuticals, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
BioMarin Pharmaceutical Inc. to acquire Amicus Therapeutics, Inc.
BioMarin Pharmaceutical Inc. and Amicus Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- BioMarin Pharmaceutical Inc.
- Target
- Amicus Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Servier to acquire Day One Biopharmaceuticals, Inc.
Servier and Day One Biopharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Servier
- Target
- Day One Biopharmaceuticals, Inc.
- Deal value
- USD 2,500,000,000
- Deal type
- going private
Aurinia Pharma U.S., Inc. to acquire Kezar Life Sciences, Inc.
Aurinia Pharma U.S., Inc. and Kezar Life Sciences, Inc. entered the Exit Mode archive.
- Buyer
- Aurinia Pharma U.S., Inc.
- Target
- Kezar Life Sciences, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Abbott to acquire Exact Sciences Corp
Abbott and Exact Sciences Corp entered the Exit Mode archive.
- Buyer
- Abbott
- Target
- Exact Sciences Corp
- Deal value
- Not disclosed
- Deal type
- going private
Buyer history
Johnson & Johnson
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive